Pressure overload-induced cardiomyopathy in heterozygous carrier mice of carnitine transporter gene mutation

Hypertension

Volumn 50, Issue 3, 2007, Pages 497-502

  Takahashi, Ryotaro ^a   Asai, Toru ^b   Murakami, Hisashi ^c   Murakami, Ryuichiro ^c   Tsuzuki, Michitaka ^c   Numaguchi, Yasushi ^d   Matsui, Hideo ^c   Murohara, Toyoaki ^c   Okumura, Kenji ^d  

^a Chunichi Hospital   (Japan)

^b Aichi Cardiovascular and Respiratory Center ^*  (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiomyopathy; Genes; Heart failure; Hypertension; Hypertrophy

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATRIAL NATRIURETIC FACTOR; CARNITINE; CREATINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; ASCENDING AORTA; CARDIOMYOPATHY; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HEART FAILURE; HEART LEFT VENTRICLE; HEART VENTRICLE OVERLOAD; HETEROZYGOTE; JUVENILE ANIMAL; LUNG CONGESTION; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEATOSIS; SUPPLEMENTATION; WILD TYPE;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOMEGALY; CARDIOMYOPATHIES; CARNITINE; CONSTRICTION; ECHOCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HYPERTENSION; LUNG; MALE; MICE; MICE, MUTANT STRAINS; MUTATION; MYOCARDIUM; ORGAN SIZE; ORGANIC CATION TRANSPORT PROTEINS; PHOSPHOCREATINE; RNA, MESSENGER;

EID: 34548184469     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.088609     Document Type: Article

References (32)

1. Neely JR, Rovetto MJ, Oram JF. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis. 1972;15:289-329.
2. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913-919.
3. Bremer J. Carnitine metabolism and functions. Physiol Rev. 1983;63:1420-1480.
4. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi A, Shoji Y, Takada G, Matsuishi T, Yoshino M, Kato H, Ohura T, Tsujimoto G, Hayakawa J, Shimane M, Tsuji A. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet. 1999;21:91-94.
5. Stanley CA, DeLeeuw S, Coates PM, Vianey-Liad C, Divry P, Bonnefont JP, Saudubray JM, Haymond M, Trefz FK, Breningstall GN, Wappner RS, Byrd DJ, Sansaricq C, Tein I, Grover W, Valle D, Rutledge SL, Treem WR. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol. 1991;30:709-716.
6. Lamhonwah AM, Olpin SE, Pollitt RJ, Vianey-Saban C, Divry P, Guffon N, Besley GTN, Onizuka R, De Meirleir LJ, Cvitanovic-Sojat L, Baric I, Dionisi-Vici C, Fumic K, Maradin M, Tein I. Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy. Am J Med Genet. 2002;111:271-284.
7. Kuwajima M, Kono N, Horiuchi M, Imamura Y, Ono A, Inui Y, Kawata S, Koizumi T, Hayakawa J, Saheki T, Tarui S. Animal model of systemic carnitine deficiency: analysis in C3H-H-2° strain of mouse associated with juvenile visceral steatosis. Biochem Biophys Res Commun. 1991;174:1090-1094.
8. Kuwajima M, Lu K, Sei M, Ono A, Hayashi M, Ishiguro K, Ozaki K, Hotta K, Okita K, Murakami T, Miyagawa J, Narama I, Nikaido H, Hayakawa J, Nakajima H, Namba M, Hanafusa T, Matsuzawa Y, Shima K. Characteristics of cardiac hypertrophy in the juvenile visceral steatosis mouse with systemic carnitine deficiency. J Mol Cell Cardiol. 1998;30:773-781.
9. Takahashi R, Okumura K, Asai T, Hirai T, Murakami H, Murakami R, Numaguchi Y, Matsui H, Ito M, Murohara T. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res. 2005;68:213-223.
10. Lahjouji K, Elimrani I, Wu J, Mitchell GA, Qureshi IA. A heterozygote phenotype is present in the jvs +/- mutant mouse livers. Mol Genet Metab. 2002;76:76-80.
11. Xiaofei E, Wada Y, Dakeishi M, Hirasawa F, Murata K, Masuda H, Sugiyama T, Nikaido H, Koizumi A. Age-associated cardiomyopathy in heterozygous carrier mice of a pathological mutation of carnitine transporter gene, OCTN2. J Gerontol. 2002;57A:B270-B278.
12. Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, Ohashi R, Tamai I, Shoji Y, Takada G, Kibara S, Matsuishi T, Tsuji A. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999;8:2247-2254.
13. Tein I. Carnitine transport: pathophysiology and metabolism of known molecular defects. J Inherit Metab Dis. 2003;26:147-169.
14. McGarry JD, Foster, DW. Free and esterified carnitine. Radiometric method. In: Bergmeyer J, Graβl M, eds. Methods of Enzymatic Analysis. New York, NY: Academic Press; 1981:474-488.
15. Asai T, Okumura K, Takahashi R, Matsui H, Numaguchi Y, Murakami H, Murakami R, Murohara T. Combined therapy with PPARα agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res. 2006;70:566-577.
16. Volonté MG, Yuln G, Quiroga P, Consolini AE. Development of an HPLC method for determination of metabolic compounds in myocardial tissue. J Pharm Biomed Anal. 2004;35:647-653.
17. Kagaya Y, Kanno Y, Takeyama D, Ishide N, Maruyama Y, Takahashi T, Ido T, Takishima T. Effects of long-term pressure overload on regional myocardial glucose and free fatty acid uptake in rats. Circulation. 1990;81:1353-1361.
18. Allard MF, Schonekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol. 1994;267:H742-H750.
19. Christe ME, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol. 1994;26:1371-1375.
20. Liao R, Jain M, Cui L, D'Agostino J, Aiello F, Luptak I, Ngoy S, Mortensen RM, Tian R. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 2002;106:2125-2131.
21. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093-1129.
22. Lee L, Campbell R, Scheuermann-Freestone M, Taylor R, Gunaruwan P, Williams L, Ashrafian H, Horowitz J, Fraser AG, Clarke K, Frenneaux M. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment. Circulation. 2005;112:3280-3288.
23. Takahashi R, Okumura K, Matsui H, Saburi Y, Kamiya H, Matsubara K, Asai T, Ito M, Murohara T. Impact of α-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol. Cardiovasc Res. 2003;58:565-574.
24. Olson RE. Abnormalities of myocardial metabolism. Circ Res. 1964;14/15(suppl II):II109 -II115.
25. Pool PE, Chandler EH, Sonnenblick, Braunwald E. Integrity of energy stores in cat papillary muscle. Circ Res. 1968;22:213-219.
26. Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322:110-111.
27. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res. 2004;95:135-145.
28. Alpert NR, Mulieri LA, Hasenfuss G. Myocardial chemo-mechanical energy transduction. In: Fozzard HA, Haber E, Katz AM, Jennings R, Morgan H, eds. The Heart and Cardiovascular System. New York, NY: Raven Press; 1992:111-128.
29. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
30. Jamshidi Y, Montgomery HE, Hense HW, Myerson SG, Torra IP, Staels B, World MJ, Doering A, Erdmann J, Hengstenberg C, Humphries SE, Schunkert H, Flavell DM. Peroxisome proliferators-activated receptor α gene regulates left ventricular growth in response to exercise and hypertension. Circulation. 2002;105:950-955.
31. de las Fuentes L, Herrero P, Peterson LR, Kelly DP, Gropler RJ, Dávilla-Román VG. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension. 2003;41:83-87.
32. Saburi Y, Okumura K, Matsui H, Hayashi K, Kamiya H, Takahashi R, Matsubara K, Ito M. Changes in distinct species of 1,2-diacylglycerol in cardiac hypertrophy due to energy metabolic disorder. Cardiovasc Res. 2003;57:92-100.